Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 4, 2004, Pages 627-629

  Samuels, Louis E ^a,b   Holmes, Elena C ^a   Lee, Letwin ^a  

^a LANKENAU HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

1; 16; 17; 22

Indexed keywords

AMIODARONE; MILRINONE; NESIRITIDE; NORADRENALIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG USE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART INDEX; HEART SURGERY; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; LUNG ARTERY PRESSURE; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL RISK; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; CARDIAC SURGICAL PROCEDURES; COMBINED MODALITY THERAPY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN;

EID: 4644290707     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.02.025     Document Type: Article

References (8)

1. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure a randomized controlled trial. JAMA. 287:2002;1531-1540
2. Michaels A.D., Klein A., Madden J.A. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake. Circulation. 107:2003;2697-2701
3. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., Johnson A.D., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 343:2000;246-253
4. Marcus L.S., Hart D., Packer M., Yushak M., Medina N., Danziger R.S., et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation. 94:1996;3184-3189
5. Aronson D., Burger A.J. Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure. Am J Cardiol. 90:2002;435-438
6. Truong KM, Bernabei AF, Czerska B. Nesiritide use in end stage heart failure. International Heart Lung Transplant Meeting 2003:Abstract 113
7. Tann SM. B-Natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. International Heart Lung Transplant Meeting 2003:Abstract 257
8. Moazami N., Damiano R.J., Bailey M.S., Hess R.L., Lawton J.S., Moon M.R., et al. Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg. 75:2003;1974-1976